National Stroke Foundation

Glyburide Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved December 1997

Specific Treatments:

blood-glucose lowering agent

Therapeutic Areas

General Information

Klonopin has been approved in a lypophilized wafer formula for 0.125mg, 0.25mg, 0.5mg, 1mg, and 2mg strengths.